1
Clinical Trials associated with Cord Blood Derived CAR-T Cells(Henan Hualong Biotechnology) / Unknown statusPhase 1IIT Clinical Study of Cord Blood Derived CAR-T Cells in Patients With Refractory/Relapsed B Cell Leukemia/Lymphoma Who Are Failed for Autologous CAR-T Cells or Autologous CAR-T Can Not be Prepared
Evaluation the safety and efficacy of cord blood-derived CAR-T cells in patients with relapsed/refractory B cell leukemia/lymphoma whose disease relapsed after autologous CAR-T cells therapy or who fail to preparation for autologous CAR-T cells
100 Clinical Results associated with Cord Blood Derived CAR-T Cells(Henan Hualong Biotechnology)
100 Translational Medicine associated with Cord Blood Derived CAR-T Cells(Henan Hualong Biotechnology)
100 Patents (Medical) associated with Cord Blood Derived CAR-T Cells(Henan Hualong Biotechnology)
100 Deals associated with Cord Blood Derived CAR-T Cells(Henan Hualong Biotechnology)